Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aphria Inc. APHA

Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer


NDAQ:APHA - Post by User

Bullboard Posts
Comment by Donbgamecockon Oct 15, 2019 9:30am
93 Views
Post# 30230930

RE:We bet on the right horse

RE:We bet on the right horse

gottahunch wrote: That is what has just been proven in this news release. An EPS beat and increase in cannabis revenue. There was a decrease in CC Pharma and total revenue therefore we came in less than I thought we would between this and the small effect of the fire at BC, but the reality is that I believe we have proven that this business model works. Two positive quarters, earnings going up, and DD approval on deck. I cannot see how the insituations will not take note of this and provide positive coverage. However, the CIBC idiot is so arrogant, maybe he'll double down on his predictions and continue to look like a fool.  It's my hope the rampant short manipulating will stop as we transition to more of a tradistional business as opposed to a speculative one.

Aphria has always been an execution story, that is why I bought in and believed in the company. Vic messed up deals but set up the business right and CC Pharma was a steal.  Most of the rest of the sector has been a joke. Canopy is smoke and mirrors, ACB is a diluting share printing machine, hexo can't sell, TRST are criminals, Alefia are a bunch of liars, the list goes on and on. The possible exceptions being OGI and perhaps VFF.

We really need positive coverage and constant pressure on the shorts. They should go pick on the companies that are failing at this point.

Thanks to all who have contributed during these trying times.

 

I agree whole heartedly.  But, I think the CIBC idiot already double downed this qtr.  He'll triple down come Jan. 

Bullboard Posts